Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.57 |
| ▸ | HCRTR2 | O43614 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | PADI4 | Q9UM07 | 3/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.34 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.34 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2054210 | 0.87 | HCRTR1 (0.60) | HCRTR1HCRTR2NPC1RAB9APADI4 | |
| SCHEMBL2054212 | 0.87 | HCRTR1 (0.60) | HCRTR1HCRTR2NPC1RAB9APADI4 | |
| SCHEMBL2011075 | 0.87 | HCRTR1 (0.62) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL2014386 | 0.84 | HCRTR1 (0.42) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL6919546 | 0.84 | HCRTR1 (0.41) | HCRTR1HCRTR2NPC1RAB9AHRH3 | |
| SCHEMBL2016006 | 0.84 | HCRTR1 (0.60) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL2015135 | 0.83 | HCRTR1 (0.59) | HCRTR1HCRTR2NPC1RAB9APADI4 | |
| SCHEMBL13139060 | 0.82 | HCRTR1 (0.77) | HCRTR1HCRTR2NPC1RAB9APADI4 | |
| SCHEMBL2017389 | 0.81 | HCRTR1 (0.41) | HCRTR1HCRTR2NPC1RAB9A | |
| SCHEMBL2012839 | 0.81 | HCRTR1 (0.59) | HCRTR1HCRTR2NPC1RAB9APADI4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011073316-A1 | 4-ARYL-BUTANE-1,3-DIAMIDES | NOVARTIS AG (CH) | 2011-06-23 | — | — | WO | disclosed |